FUJIFILM Wako Pure Chemical Corp. produces and wholesales clinical diagnostic reagents, electronic materials, and chemical products. The firm offers product information, laboratory chemicals, specialty chemicals, clinical diagnostic reagents and equipment. The company was founded in 1922 and is headquartered in Osaka, Japan.

Genetics Institute is a U.S. based biotechnology research and development company. The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells. The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of Ptashne’s home. Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.

Part of Jazz Pharmaceuticals Plc, Gentium SpA is a company headquartered in Italy. The firm engages in research and development activities of prospective pharmaceutical specialty products.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

Aptarion Biotech Ag is a private company headquartered in Germany that develops biostable L-aptamers for the treatment of life-threatening diseases and for biosensors.

Nippon Shinyaku Co., Ltd. engages in the manufacture and sale of pharmaceuticals and foodstuffs. Its operations are carried out through the Pharmaceuticals and Functional Food divisions. The Pharmaceuticals division develops and distributes drugs that treat urological diseases, inflammation, allergies, hematological malignancies, cardiovascular and metabolic diseases, and gastrointestinal disorders. The Functional Food division manufactures and supplies health food ingredients, preservatives, protein preparations, nutritional ingredients, seasonings and spices, and sterilization cleaning agents. The company was founded on November 20, 1911 and is headquartered Kyoto, Japan.

Nippon Gene Co., Ltd. manufactures research tools, human IVDs (In vitro diagnostics), and non-human IVDs. It provides restriction enzymes, modifying enzymes, plasmid, primers and probes, agarose, buffers, reagents for LAMP and PCR, plant disease diagnostic kits, allergen detection kits, agrichemical detection kits, antibiotics detection kits, GMO detection reagents and others. The company was founded on January 25, 1982 and is headquartered in Toyama, Japan.

Suzhou GenePharma Co.,Ltd. engages in the manufacture of biotechnology products. Its products cover chemically-synthetic RNA monomer, custom siRNA oligo, chemically-modified RNA oligo, fluorescent dye for biological macromolecules marker; Biosynthesis siRNA, shRNA; DNAs encoding shRNA, plasmid vector encoding shRNA; RNAi service based on chemical synthesis, RNAi service based on vector regulation; siRNA related reagents and RNA-related product sales; common molecular biology reagent and laboratory supplies sales. The company was founded on August 27, 2007 and is headquartered in Shanghai, China.

Medisorb Technologies International LP, part of Alkermes Plc, is a company headquartered in Cincinnati, OH. The firm develops drug delivery systems. It was founded by Danny H. Lewis. Medisorb Technologies International LP was acquired by Alkermes, Inc., now part of Alkermes Plc on March 11, 1996 for $5 million.

Exocobio, Inc. engages in developing cosmeceuticals, cosmetic medical devices and bio-pharmaceuticals for skin and tissue regeneration. The company was founded by Cho Byeong-Seong on January 3, 2017 and is headquartered in Seoul, South Korea.

Designs lab instruments systems

Life-Tech, Inc. is a private company headquartered in Stafford, TX, with a presence in the United States, that manufactures and markets medical devices.

Seegene, Inc. engages in the manufacturing and distributing of molecular diagnostics and reagents. Its diagnostic services include respiratory pathogen, gastrointestinal pathogen, sexually transmitted infections, human papillomavirus, tuberculosis, sepsis, meningitis, and pathogen. The company was founded by Jong-Yoon Chun on September 16, 2000 and is headquartered in Seoul, South Korea.

Anhui Tianzhizheng Biotechnology Co., Ltd., established on 2014-04-15, Business scope includes biomedicine,modern agriculture,Functional food science and technology project research and development,technology transfer,consult,project agent,Serve,scientific literature,Information Consulting Service,Production and design services of scientific and technological tender documents,Scientific reagents,Experimental Materials,reference book,Consumables Sales.

MOLOGEN AG engages in the research and clinical development of drugs in the fields of oncology and infectious diseases. Its products include lefitolimod and its follow-up molecules EnanDIM, and cell-based therapeutic vaccine MGN1601. The company was founded by Matthias P. Schlichting and Burghardt Wittig on January 14, 1998 and is headquartered in Berlin, Germany.